Your browser doesn't support javascript.
loading
Will post-transplantation cell therapies for pediatric patients become standard of care?
Lankester, Arjan C; Locatelli, Franco; Bader, Peter; Rettinger, Eva; Egeler, Maarten; Katewa, Satyendra; Pulsipher, Michael A; Nierkens, Stefan; Schultz, Kirk; Handgretinger, Rupert; Grupp, Stephan A; Boelens, Jaap Jan; Bollard, Catherine M.
Afiliação
  • Lankester AC; Division of Stem Cell Transplantation, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.lankester@lumc.nl.
  • Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale Pediatrico, Bambino Gesù, Rome, Italy.
  • Bader P; Department of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Frankfurt am Main, Germany.
  • Rettinger E; Department of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Frankfurt am Main, Germany.
  • Egeler M; Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Katewa S; Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Pulsipher MA; Primary Children's Hospital, Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute/University of Utah School of Medicine, Salt Lake City, Utah.
  • Nierkens S; Utrecht-Dendritic cells AgaiNst CancEr (U-DANCE), Lab Translational Immunology, Utrecht center for Diagnostic Advances in Immunology Research (U-DAIR), Lab Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Schultz K; BC Children's Hospital, Division of Oncology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Handgretinger R; Department of Pediatric Hematology/Oncology, Children's University Hospital, University of Tübingen, Tübingen, Germany.
  • Grupp SA; Division of Oncology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Boelens JJ; Department of Pediatrics, Blood and Marrow Transplantation Program, Utrecht-Dendritic cells AgaiNst CancEr (U-DANCE), Lab Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bollard CM; Departments of Pediatrics and Microbiology, Immunology and Tropical Medicine, Children's National Health System and George Washington University, Division of Pediatric Hematology-Oncology, Washington, DC.
Biol Blood Marrow Transplant ; 21(3): 402-11, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25064748
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Efeito Enxerto vs Tumor / Terapia Baseada em Transplante de Células e Tecidos / Rejeição de Enxerto / Doença Enxerto-Hospedeiro Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Efeito Enxerto vs Tumor / Terapia Baseada em Transplante de Células e Tecidos / Rejeição de Enxerto / Doença Enxerto-Hospedeiro Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article